source Post navigation Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes – Northeast Mississippi Daily Journal Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial – BioSpace